moxifloxacin has been researched along with Cholecystitis, Acute in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackmann, S; Baron, A; Büchler, MW; Daniel, D; Encke, J; Feilhauer, K; Golling, MT; Götze, T; Gutt, CN; Harnoss, JC; Kipfmüller, K; Klar, E; Köninger, J; Menges, M; Ridwelski, K; Schön, MR; Schunter, O; Seitz, HK; Stremmel, W; Weigand, K; Zoller, WG | 1 |
| Büchler, MW; Strobel, O | 1 |
2 trial(s) available for moxifloxacin and Cholecystitis, Acute
| Article | Year |
|---|---|
Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304).
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Combined Modality Therapy; Conversion to Open Surgery; Cost-Benefit Analysis; Drug Administration Schedule; Female; Fluoroquinolones; Germany; Hospital Costs; Humans; Intention to Treat Analysis; Length of Stay; Male; Middle Aged; Moxifloxacin; Postoperative Complications; Prospective Studies; Quinolines; Slovenia; Time Factors; Treatment Outcome | 2013 |
[Early laparoscopic cholecystectomy as therapy of choice for acute cholecystitis].
Topics: Anti-Bacterial Agents; Aza Compounds; Cholecystectomy, Laparoscopic; Cholecystitis, Acute; Conversion to Open Surgery; Early Medical Intervention; Fluoroquinolones; Hospital Costs; Humans; Infusions, Intravenous; Length of Stay; Moxifloxacin; Postoperative Complications; Quinolines | 2013 |